United States Pharmaceuticals

SCYNEXIS Inc (SCYX)

Track

Track

SCYNEXIS Inc experienced significant insider trading activity throughout late 2024. Major shareholders, specifically Federated Hermes entities, executed multiple proposed sales of common stock during December. The most recent transactions occurred on December 18, 2024. These divestments follow a series of similar filings by the same institutional holders earlier that month.
Ticker: SCYX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for SCYNEXIS Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.9
Angulo Gonzalez David Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
1.37
Quantity 20,000 +4.1%
Value US$27,400
3.8
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.00
Quantity 75,000 +38.1%
Value US$225,000
3.2
Sukenick Scott General Counsel Officer
Transaction date
Purchase
Price
3.00
Quantity 3,500 +7.0%
Value US$10,500
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
8.16
Quantity 285,151 -13.5%
Value US$2,326,832
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
7.43
Quantity 185,000 -7.7%
Value US$1,374,550
3.2
ANIDO ARMANDO Non-Executive Director
Transaction date
Purchase
Price
6.25
Quantity 5,000 +inf%
Value US$31,250
3.2
HANHAM ANN Non-Executive Director
Transaction date
Purchase
Price
6.25
Quantity 3,200 +758.3%
Value US$20,000
3.2
Francois Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
6.25
Quantity 600 +5.4%
Value US$3,750
3.2
Tinmouth Brian Philippe Non-Executive Director
Transaction date
Purchase
Price
6.25
Quantity 8,000 +inf%
Value US$50,000
3.8
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
6.25
Quantity 40,000 +57.4%
Value US$250,000
3.2
Sukenick Scott General Counsel Officer
Transaction date
Purchase
Price
6.25
Quantity 1,600 +21.3%
Value US$10,000
3.2
Macdonald Guy Non-Executive Director
Transaction date
Purchase
Price
6.25
Quantity 8,000 +200.0%
Value US$50,000
3.2
GILMAN STEVEN C Non-Executive Director
Transaction date
Purchase
Price
6.25
Quantity 4,000 +inf%
Value US$25,000
3.9
Angulo Gonzalez David Chief Medical Officer Officer
Transaction date
Purchase
Price
6.25
Quantity 1,600 +7.2%
Value US$10,000
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.90
Quantity 166,667 +31.6%
Value US$150,000
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.11
Quantity 9,500 +1.8%
Value US$10,545
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.11
Quantity 500 +0.1%
Value US$555
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.01
Quantity 10,015 +2.0%
Value US$10,115
3.8
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.63
Quantity 25,000 +5.2%
Value US$40,750
3.8
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.69
Quantity 25,000 +5.5%
Value US$17,250
3.8
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.46
Quantity 25,000 +5.8%
Value US$11,500
3.9
Angulo Gonzalez David Chief Medical Officer Officer
Transaction date
Purchase
Price
0.50
Quantity 12,000 +10.9%
Value US$5,951
Angulo Gonzalez David Chief Medical Officer Officer
Transaction date
Purchase
Price
1.27
Quantity 7,000 +6.9%
Value US$8,890
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.29
Quantity 25,000 +6.2%
Value US$32,250
Angulo Gonzalez David Chief Medical Officer
Transaction date
Purchase
Price
1.36
Quantity 6,000 +6.3%
Value US$8,160
HASTINGS DAVID C
Transaction date
Purchase
Price
1.69
Quantity 11,834 +59.2%
Value US$19,999
Sukenick Scott General Counsel
Transaction date
Purchase
Price
1.69
Quantity 2,959 +inf%
Value US$5,001
Francois Eric Chief Financial Officer
Transaction date
Purchase
Price
1.69
Quantity 5,917 +31.1%
Value US$10,000
Angulo Gonzalez David Chief Medical Officer
Transaction date
Purchase
Price
1.69
Quantity 14,790 +20.0%
Value US$24,995
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.69
Quantity 100,000 +32.9%
Value US$169,000
Angulo Gonzalez David Chief Medical Officer
Transaction date
Purchase
Price
1.39
Quantity 7,000 +7.9%
Value US$9,730
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.23
Quantity 10,000 +3.4%
Value US$22,300
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.85
Quantity 4,993 +1.7%
Value US$9,237
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.61
Quantity 7 +0.0%
Value US$11
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.61
Quantity 10,000 +3.6%
Value US$16,100
Angulo Gonzalez David Chief Medical Officer
Transaction date
Purchase
Price
1.55
Quantity 10,000 +16.1%
Value US$15,500
HASTINGS DAVID C
Transaction date
Purchase
Price
1.75
Quantity 20,000 +inf%
Value US$35,000
Angulo Gonzalez David Chief Medical Officer Officer
Transaction date
Purchase
Price
1.70
Quantity 15,000 +31.9%
Value US$25,500
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.69
Quantity 25,000 +9.9%
Value US$42,250
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.30
Quantity 25,000 +11.1%
Value US$82,500
Angulo Gonzalez David Chief Medical Officer Officer
Transaction date
Purchase
Price
3.25
Quantity 4,000 +9.5%
Value US$13,000
Machado Patrick Non-Executive Director
Transaction date
Purchase
Price
2.94
Quantity 40,000 +200.0%
Value US$117,600
Angulo Gonzalez David Chief Medical Officer Officer
Transaction date
Purchase
Price
2.23
Quantity 32,150 +363.3%
Value US$71,694
Angulo Gonzalez David Chief Medical Officer Officer
Transaction date
Purchase
Price
2.18
Quantity 4,800 +118.5%
Value US$10,464
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.39
Quantity 100,000 +80.0%
Value US$239,000
Francois Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
2.39
Quantity 15,000 +inf%
Value US$35,850
Machado Clarence Patrick Non-Executive Director
Transaction date
Purchase
Price
2.39
Quantity 20,000 +inf%
Value US$47,800
Macdonald Guy Non-Executive Director
Transaction date
Purchase
Price
2.39
Quantity 40,000 +inf%
Value US$95,600
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.26
Quantity 5,754 +4.8%
Value US$18,758
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.20
Quantity 246 +0.2%
Value US$787
HANHAM ANN Non-Executive Director
Transaction date
Purchase
Price
3.64
Quantity 4,225 +inf%
Value US$15,379
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.37
Quantity 5,500 +4.8%
Value US$18,535
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.15
Quantity 3,000 +2.7%
Value US$9,450
Taglietti Marco Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.14
Quantity 4,500 +4.2%
Value US$14,130
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-18 2024-12-18 PrS Proposed sale
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series

10% Stockholder

Large shareholder
71,316
32.14
US$3,344,380 		71,316 32.14 US$3,344,380
2024-12-18 2024-12-18 PrS Proposed sale
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series

10% Stockholder

Large shareholder
67,670
78.66
US$3,677,752 		67,670 78.66 US$3,677,752
2024-12-18 2024-12-18 PrS Proposed sale
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
57,451
376.31
US$4,401,493 		57,451 376.31 US$4,401,493
2024-12-18 2024-12-18 PrS Proposed sale
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
128,957
1.23
US$158,617 		128,957 1.23 US$158,617
2024-12-18 2024-12-18 PrS Proposed sale
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
166,334
1.23
US$204,591 		166,334 1.23 US$204,591
2024-12-18 2024-12-18 PrS Proposed sale
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
166,334
1.23
US$204,591 		166,334 1.23 US$204,591
2024-12-11 2024-12-11 PrS Proposed sale
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series

10% Stockholder

Large shareholder
10,988
1.23
US$13,515 		10,988 1.23 US$13,515
2024-12-11 2024-12-11 PrS Proposed sale
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity FUnds

10% Stockholder

Large shareholder
300,899
1.23
US$370,106 		300,899 1.23 US$370,106
2024-12-11 2024-12-11 PrS Proposed sale
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
388,113
1.23
US$477,379 		388,113 1.23 US$477,379
2024-09-16 2024-09-12 PP Planned purchase
3.9
Angulo Gonzalez David

Chief Executive Officer

Executive Director
20,000 +4.1%
1.37
US$27,400 		20,000 +4.1% 1.37 US$27,400
2024-08-27 2024-08-22 PrS Proposed sale
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series

10% Stockholder

Large shareholder
9,700
1.77
US$17,169 		9,700 1.77 US$17,169
2024-08-27 2024-08-22 PrS Proposed sale
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
272,000
1.77
US$481,440 		272,000 1.77 US$481,440
2024-08-27 2024-08-22 PrS Proposed sale
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
338,000
1.77
US$598,260 		338,000 1.77 US$598,260
2024-08-22 2024-08-22 PrS Proposed sale
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series

10% Stockholder

Large shareholder
9,700
1.77
US$17,169 		9,700 1.77 US$17,169
2024-08-22 2024-08-22 PrS Proposed sale
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
272,000
1.77
US$481,440 		272,000 1.77 US$481,440
2024-08-22 2024-08-22 PrS Proposed sale
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
338,000
1.77
US$598,260 		338,000 1.77 US$598,260
2024-02-09 2024-02-09 PrS Proposed sale
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
477,101
2.14
US$1,020,996 		477,101 2.14 US$1,020,996
2024-02-05 2024-02-05 PrS Proposed sale
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
590,000
2.14
US$1,262,600 		590,000 2.14 US$1,262,600
2023-09-22 2023-09-21 PrS Proposed sale
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series

10% Stock

Large shareholder
9,214
3.42
US$31,539 		9,214 3.42 US$31,539
2023-09-22 2023-09-21 PrS Proposed sale
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds

10% Stockholder

Large shareholder
360,000
3.42
US$1,232,244 		360,000 3.42 US$1,232,244
2022-04-28 2022-04-26 B Purchase
3.8
Taglietti Marco

Chief Executive Officer

Executive Director
75,000 +38.1%
3.00
US$225,000 		75,000 +38.1% 3.00 US$225,000
2022-04-28 2022-04-26 B Purchase
3.2
Sukenick Scott

General Counsel

Officer
3,500 +7.0%
3.00
US$10,500 		3,500 +7.0% 3.00 US$10,500
2021-01-26 2021-01-22 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
33,849 -1.8%
8.95
US$302,949 		33,849 -1.8% 8.95 US$302,949
2021-01-26 2021-01-22 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
285,151 -13.5%
8.16
US$2,326,832 		285,151 -13.5% 8.16 US$2,326,832
2021-01-26 2021-01-21 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
95,000 -4.3%
7.38
US$701,100 		95,000 -4.3% 7.38 US$701,100
2021-01-26 2021-01-20 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
185,000 -7.7%
7.43
US$1,374,550 		185,000 -7.7% 7.43 US$1,374,550
2020-12-23 2020-12-21 B Purchase
3.2
ANIDO ARMANDO
Non-Executive Director
5,000 +inf%
6.25
US$31,250 		5,000 +inf% 6.25 US$31,250
2020-12-23 2020-12-21 B Purchase
3.2
HANHAM ANN
Non-Executive Director
3,200 +758.3%
6.25
US$20,000 		3,200 +758.3% 6.25 US$20,000
2020-12-23 2020-12-21 B Purchase
3.2
Francois Eric

Chief Financial Officer

Officer
600 +5.4%
6.25
US$3,750 		600 +5.4% 6.25 US$3,750
2020-12-23 2020-12-21 B Purchase
3.2
Tinmouth Brian Philippe
Non-Executive Director
8,000 +inf%
6.25
US$50,000 		8,000 +inf% 6.25 US$50,000
2020-12-23 2020-12-21 B Purchase
3.8
Taglietti Marco

Chief Executive Officer

Executive Director
40,000 +57.4%
6.25
US$250,000 		40,000 +57.4% 6.25 US$250,000
2020-12-23 2020-12-21 B Purchase
3.2
Sukenick Scott

General Counsel

Officer
1,600 +21.3%
6.25
US$10,000 		1,600 +21.3% 6.25 US$10,000
2020-12-23 2020-12-21 B Purchase
3.2
Macdonald Guy
Non-Executive Director
8,000 +200.0%
6.25
US$50,000 		8,000 +200.0% 6.25 US$50,000
2020-12-23 2020-12-21 B Purchase
3.2
GILMAN STEVEN C
Non-Executive Director
4,000 +inf%
6.25
US$25,000 		4,000 +inf% 6.25 US$25,000
2020-12-23 2020-12-21 B Purchase
3.9
Angulo Gonzalez David

Chief Medical Officer

Officer
1,600 +7.2%
6.25
US$10,000 		1,600 +7.2% 6.25 US$10,000
2019-12-16 2019-12-12 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
166,667 +31.6%
0.90
US$150,000 		166,667 +31.6% 0.90 US$150,000
2019-08-22 2019-08-21 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
9,500 +1.8%
1.11
US$10,545 		9,500 +1.8% 1.11 US$10,545
2019-08-22 2019-08-20 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
500 +0.1%
1.11
US$555 		500 +0.1% 1.11 US$555
2019-08-19 2019-08-15 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
10,015 +2.0%
1.01
US$10,115 		10,015 +2.0% 1.01 US$10,115
2019-04-18 2019-04-17 B Purchase
3.8
Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +5.2%
1.63
US$40,750 		25,000 +5.2% 1.63 US$40,750
2019-01-14 2019-01-10 B Purchase
3.8
Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +5.5%
0.69
US$17,250 		25,000 +5.5% 0.69 US$17,250
2019-01-02 2018-12-31 B Purchase
3.8
Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +5.8%
0.46
US$11,500 		25,000 +5.8% 0.46 US$11,500
2019-01-02 2018-12-31 B Purchase
3.9
Angulo Gonzalez David

Chief Medical Officer

Officer
12,000 +10.9%
0.50
US$5,951 		12,000 +10.9% 0.50 US$5,951
2018-09-10 2018-09-06 B Purchase Angulo Gonzalez David

Chief Medical Officer

Officer
7,000 +6.9%
1.27
US$8,890 		7,000 +6.9% 1.27 US$8,890
2018-08-27 2018-08-23 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +6.2%
1.29
US$32,250 		25,000 +6.2% 1.29 US$32,250
2018-04-02 2018-03-29 B Purchase Angulo Gonzalez David

Chief Medical Officer
6,000 +6.3%
1.36
US$8,160 		6,000 +6.3% 1.36 US$8,160
2018-03-12 2018-03-08 B Purchase HASTINGS DAVID C
11,834 +59.2%
1.69
US$19,999 		11,834 +59.2% 1.69 US$19,999
2018-03-12 2018-03-08 B Purchase Sukenick Scott

General Counsel
2,959 +inf%
1.69
US$5,001 		2,959 +inf% 1.69 US$5,001
2018-03-12 2018-03-08 B Purchase Francois Eric

Chief Financial Officer
5,917 +31.1%
1.69
US$10,000 		5,917 +31.1% 1.69 US$10,000
2018-03-12 2018-03-08 B Purchase Angulo Gonzalez David

Chief Medical Officer
14,790 +20.0%
1.69
US$24,995 		14,790 +20.0% 1.69 US$24,995
2018-03-12 2018-03-08 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
100,000 +32.9%
1.69
US$169,000 		100,000 +32.9% 1.69 US$169,000
2018-03-12 2018-03-08 B Purchase Angulo Gonzalez David

Chief Medical Officer
7,000 +7.9%
1.39
US$9,730 		7,000 +7.9% 1.39 US$9,730
2017-09-25 2017-09-22 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
10,000 +3.4%
2.23
US$22,300 		10,000 +3.4% 2.23 US$22,300
2017-08-24 2017-08-23 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
4,993 +1.7%
1.85
US$9,237 		4,993 +1.7% 1.85 US$9,237
2017-08-24 2017-08-22 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
7 +0.0%
1.61
US$11 		7 +0.0% 1.61 US$11
2017-08-17 2017-08-15 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
10,000 +3.6%
1.61
US$16,100 		10,000 +3.6% 1.61 US$16,100
2017-08-14 2017-08-11 B Purchase Angulo Gonzalez David

Chief Medical Officer
10,000 +16.1%
1.55
US$15,500 		10,000 +16.1% 1.55 US$15,500
2017-06-22 2017-06-21 B Purchase HASTINGS DAVID C
20,000 +inf%
1.75
US$35,000 		20,000 +inf% 1.75 US$35,000
2017-05-15 2017-05-12 B Purchase Angulo Gonzalez David

Chief Medical Officer

Officer
15,000 +31.9%
1.70
US$25,500 		15,000 +31.9% 1.70 US$25,500
2017-05-15 2017-05-12 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +9.9%
1.69
US$42,250 		25,000 +9.9% 1.69 US$42,250
2016-12-22 2016-12-21 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +11.1%
3.30
US$82,500 		25,000 +11.1% 3.30 US$82,500
2016-12-19 2016-12-16 B Purchase Angulo Gonzalez David

Chief Medical Officer

Officer
4,000 +9.5%
3.25
US$13,000 		4,000 +9.5% 3.25 US$13,000
2016-09-16 2016-09-15 B Purchase Machado Patrick Non-Executive Director
40,000 +200.0%
2.94
US$117,600 		40,000 +200.0% 2.94 US$117,600
2016-07-01 2016-06-30 B Purchase Angulo Gonzalez David

Chief Medical Officer

Officer
32,150 +363.3%
2.23
US$71,694 		32,150 +363.3% 2.23 US$71,694
2016-07-01 2016-06-29 B Purchase Angulo Gonzalez David

Chief Medical Officer

Officer
4,800 +118.5%
2.18
US$10,464 		4,800 +118.5% 2.18 US$10,464
2016-06-28 2016-06-24 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
100,000 +80.0%
2.39
US$239,000 		100,000 +80.0% 2.39 US$239,000
2016-06-28 2016-06-24 B Purchase Francois Eric

Chief Financial Officer

Officer
15,000 +inf%
2.39
US$35,850 		15,000 +inf% 2.39 US$35,850
2016-06-28 2016-06-24 B Purchase Machado Clarence Patrick Non-Executive Director
20,000 +inf%
2.39
US$47,800 		20,000 +inf% 2.39 US$47,800
2016-06-28 2016-06-24 B Purchase Macdonald Guy Non-Executive Director
40,000 +inf%
2.39
US$95,600 		40,000 +inf% 2.39 US$95,600
2016-05-27 2016-05-25 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
5,754 +4.8%
3.26
US$18,758 		5,754 +4.8% 3.26 US$18,758
2016-05-27 2016-05-25 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
246 +0.2%
3.20
US$787 		246 +0.2% 3.20 US$787
2016-05-27 2016-05-25 B Purchase HANHAM ANN Non-Executive Director
4,225 +inf%
3.64
US$15,379 		4,225 +inf% 3.64 US$15,379
2016-05-25 2016-05-24 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
5,500 +4.8%
3.37
US$18,535 		5,500 +4.8% 3.37 US$18,535
2016-05-24 2016-05-23 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
3,000 +2.7%
3.15
US$9,450 		3,000 +2.7% 3.15 US$9,450
2016-05-24 2016-05-20 B Purchase Taglietti Marco

Chief Executive Officer

Executive Director
4,500 +4.2%
3.14
US$14,130 		4,500 +4.2% 3.14 US$14,130
Explore more

More insider trading research around SCYNEXIS Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America